Guoyue Lv

4.9k total citations · 1 hit paper
140 papers, 1.8k citations indexed

About

Guoyue Lv is a scholar working on Surgery, Hepatology and Epidemiology. According to data from OpenAlex, Guoyue Lv has authored 140 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Surgery, 44 papers in Hepatology and 40 papers in Epidemiology. Recurrent topics in Guoyue Lv's work include Hepatocellular Carcinoma Treatment and Prognosis (24 papers), Liver Disease Diagnosis and Treatment (24 papers) and Organ Transplantation Techniques and Outcomes (16 papers). Guoyue Lv is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (24 papers), Liver Disease Diagnosis and Treatment (24 papers) and Organ Transplantation Techniques and Outcomes (16 papers). Guoyue Lv collaborates with scholars based in China, United States and Hong Kong. Guoyue Lv's co-authors include Guangyi Wang, Lanlan Chen, Dawei Sun, Yuguo Chen, Xiaodong Sun, Wei Qiu, Jing Li, Haitao Li, Chang He and Yang Liu and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Guoyue Lv

132 papers receiving 1.8k citations

Hit Papers

Insights into modifiable risk factors of cholelithiasis: ... 2021 2026 2022 2024 2021 50 100 150

Peers

Guoyue Lv
Peng Zhu China
Yue Yu China
Jee Hyun Lee South Korea
Zhuo Li China
Peng Zhu China
Guoyue Lv
Citations per year, relative to Guoyue Lv Guoyue Lv (= 1×) peers Peng Zhu

Countries citing papers authored by Guoyue Lv

Since Specialization
Citations

This map shows the geographic impact of Guoyue Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guoyue Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guoyue Lv more than expected).

Fields of papers citing papers by Guoyue Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guoyue Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guoyue Lv. The network helps show where Guoyue Lv may publish in the future.

Co-authorship network of co-authors of Guoyue Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Guoyue Lv. A scholar is included among the top collaborators of Guoyue Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guoyue Lv. Guoyue Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Zengli, Zhongqi Fan, Kangshuai Li, et al.. (2024). Function of mast cell and bile-cholangiocarcinoma interplay in cholangiocarcinoma microenvironment. Gut. 73(8). 1350–1363. 10 indexed citations
2.
Dong, Ting, Guangan Hu, Zhongqi Fan, et al.. (2024). Activation of GPR3-β-arrestin2-PKM2 pathway in Kupffer cells stimulates glycolysis and inhibits obesity and liver pathogenesis. Nature Communications. 15(1). 807–807. 24 indexed citations
3.
Zhu, Xiaoxue, et al.. (2024). Evaluating the efficacy of 8 non-invasive models in predicting MASLD and progression: a prospective study. BMC Gastroenterology. 24(1). 365–365. 2 indexed citations
4.
Shi, Xiaoju, Qianqian Zheng, Xingtong Wang, et al.. (2024). Compromised macrophages contribute to progression of MASH to hepatocellular carcinoma in FGF21KO mice. Science Advances. 10(43). eado9311–eado9311. 5 indexed citations
5.
Yao, Haochen, Juanjuan Huang, Xinghui Si, et al.. (2024). Trojan‐Horse Strategy Targeting the Gut‐Liver Axis Modulates Gut Microbiome and Reshapes Microenvironment for Orthotopic Hepatocellular Carcinoma Therapy. Advanced Science. 11(44). e2310002–e2310002. 9 indexed citations
6.
Sun, Li‐Yang, Yong‐Kang Diao, Zhuping Fan, et al.. (2023). Comparison between models for detecting hepatocellular carcinoma in patients with chronic liver diseases of various etiologies: ASAP score versus GALAD score. Hepatobiliary & pancreatic diseases international. 24(4). 412–422. 9 indexed citations
7.
Jiang, Chao, et al.. (2023). Nomogram for Estimation of Acute Liver Failure Risk in Spontaneous Ruptured Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 10. 2223–2237. 1 indexed citations
9.
Sun, Kai, Shuo Jin, Kaiyu Wang, et al.. (2023). Predicting the outcomes of hepatocellular carcinoma downstaging with the use of clinical and radiomics features. BMC Cancer. 23(1). 858–858. 5 indexed citations
10.
Yao, Zhi, et al.. (2023). Immature and activated phenotype of blood NK cells is associated with acute rejection in adult liver transplant. Liver Transplantation. 29(8). 836–848. 3 indexed citations
11.
Chen, Lanlan, Wei Qiu, Xiaodong Sun, et al.. (2023). Novel insights into causal effects of serum lipids and lipid-modifying targets on cholelithiasis. Gut. 73(3). 521–532. 29 indexed citations
12.
Li, Yongqi, Yang Yang, Tianyang Li, et al.. (2023). Activation of AIM2 by hepatitis B virus results in antiviral immunity that suppresses hepatitis C virus during coinfection. Journal of Virology. 97(10). e0109023–e0109023. 5 indexed citations
13.
Qiu, Wei, Xiaodong Sun, Ying Liu, et al.. (2023). Gut microbiota dynamics in a 1-year follow-up after adult liver transplantation in Northeast China. Frontiers in Physiology. 14. 1266635–1266635. 2 indexed citations
14.
Fan, Zhongqi, Yutao Liu, Chengcheng Li, et al.. (2023). T proliferating cells derived autophagy signature associated with prognosis and immunotherapy resistance in a pan-cancer analysis. iScience. 27(1). 108701–108701. 8 indexed citations
15.
Sun, Xiaodong, et al.. (2022). The Mechanisms of Systemic Inflammatory and Immunosuppressive Acute-on-Chronic Liver Failure and Application Prospect of Single-Cell Sequencing. Journal of Immunology Research. 2022. 1–18. 7 indexed citations
16.
Gao, Wenying, Zhaolong Li, Qingtian Guan, et al.. (2022). Characterization and analysis of linear epitopes corresponding to SARS‐CoV‐2 outbreak in Jilin Province, China. Journal of Medical Virology. 95(1). e28323–e28323. 4 indexed citations
17.
Gao, Wenying, Xiaohui Ju, Zhaolong Li, et al.. (2022). The Deubiquitinase USP29 Promotes SARS-CoV-2 Virulence by Preventing Proteasome Degradation of ORF9b. mBio. 13(3). e0130022–e0130022. 20 indexed citations
18.
Li, Shuxuan, et al.. (2020). Fast-growing epithelioid hemangioendothelioma of the liver. Medicine. 99(36). e22077–e22077. 3 indexed citations
19.
Qi, Jun, et al.. (2019). Mixed adenoneuroendocrine carcinoma of the extrahepatic bile duct: a case report. Journal of International Medical Research. 47(7). 3421–3426. 5 indexed citations
20.
Liu, Xingkai, Dawei Sun, Guangyi Wang, et al.. (2019). Hem-o-lok clip found in the common bile duct 3 years after laparoscopic cholecystectomy and surgical exploration. Journal of International Medical Research. 47(2). 1052–1058. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026